Literature DB >> 34558293

Clinical impact of ultra-high b-value (3000 s/mm2) diffusion-weighted magnetic resonance imaging in prostate cancer at 3T: comparison with b-value of 2000 s/mm2.

Tsutomu Tamada1, Ayumu Kido1, Yu Ueda2, Mitsuru Takeuchi3, Takeshi Fukunaga1, Teruki Sone1, Akira Yamamoto1.   

Abstract

OBJECTIVE: High b-value diffusion-weighted imaging (hDWI) with a b-value of 2000 s/mm2 provides insufficient image contrast between benign and malignant tissues and an overlap of apparent diffusion coefficient (ADC) between Gleason grades (GG) in prostate cancer (PC). We compared image quality, PC detectability, and discrimination ability for PC aggressiveness between ultra-high b-value DWI (uhDWI) of 3000 s/mm2 and hDWI.
METHODS: The subjects were 49 patients with PC who underwent 3T multiparametric MRI. Single-shot echo-planar DWI was acquired with b-values of 0, 2000, and 3000 s/mm2. Anatomical distortion of prostate (AD), signal intensity of benign prostate (PSI), and lesion conspicuity score (LCS) were assessed using a 4-point scale; and signal-to-noise ratio, contrast-to-noise ratio, and mean ADC (×10-3 mm2/s) of lesion (lADC) and surrounding benign region (bADC) were measured.
RESULTS: PSI was significantly lower in uhDWI than in hDWI (p < 0.001). AD, LCS, signal-to-noise ratio, and contrast-to-noise ratio were comparable between uhDWI and hDWI (all p > 0.05). In contrast, lADC was significantly lower than bADC in both uhDWI and hDWI (both p < 0.001). In comparison of lADC between tumors of ≤GG2 and those of ≥GG3, both uhDWI and hDWI showed significant difference (p = 0.007 and p = 0.021, respectively). AUC for separating tumors of ≤GG2 from those of ≥GG3 was 0.731 in hDWI and 0.699 in uhDWI (p = 0.161).
CONCLUSION: uhDWI suppressed background signal better than hDWI, but did not contribute to increased diagnostic performance in PC. ADVANCES IN KNOWLEDGE: Compared with hDWI, uhDWI could not contribute to increased diagnostic performance in PC.

Entities:  

Mesh:

Year:  2021        PMID: 34558293      PMCID: PMC8978230          DOI: 10.1259/bjr.20210465

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  25 in total

1.  Abbreviated Biparametric Versus Standard Multiparametric MRI for Diagnosis of Prostate Cancer: A Systematic Review and Meta-Analysis.

Authors:  Zhen Kang; Xiangde Min; Jeffrey Weinreb; Qiubai Li; Zhaoyan Feng; Liang Wang
Journal:  AJR Am J Roentgenol       Date:  2018-12-04       Impact factor: 3.959

Review 2.  Biparametric vs multiparametric prostate magnetic resonance imaging for the detection of prostate cancer in treatment-naïve patients: a diagnostic test accuracy systematic review and meta-analysis.

Authors:  Mostafa Alabousi; Jean-Paul Salameh; Kaela Gusenbauer; Lucy Samoilov; Ali Jafri; Hang Yu; Abdullah Alabousi
Journal:  BJU Int       Date:  2019-04-25       Impact factor: 5.588

3.  Optimal high b-value for diffusion weighted MRI in diagnosing high risk prostate cancers in the peripheral zone.

Authors:  Harsh K Agarwal; Francesca V Mertan; Sandeep Sankineni; Marcelino Bernardo; Julien Senegas; Jochen Keupp; Dagane Daar; Maria Merino; Bradford J Wood; Peter A Pinto; Peter L Choyke; Baris Turkbey
Journal:  J Magn Reson Imaging       Date:  2016-07-07       Impact factor: 4.813

4.  Prostate Cancer: Diffusion-weighted MR Imaging for Detection and Assessment of Aggressiveness-Comparison between Conventional and Kurtosis Models.

Authors:  Tsutomu Tamada; Vinay Prabhu; Jianhong Li; James S Babb; Samir S Taneja; Andrew B Rosenkrantz
Journal:  Radiology       Date:  2017-04-10       Impact factor: 11.105

Review 5.  The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.

Authors:  Jonathan I Epstein; Lars Egevad; Mahul B Amin; Brett Delahunt; John R Srigley; Peter A Humphrey
Journal:  Am J Surg Pathol       Date:  2016-02       Impact factor: 6.394

6.  Histogram analysis of stretched-exponential and monoexponential diffusion-weighted imaging models for distinguishing low and intermediate/high gleason scores in prostate carcinoma.

Authors:  Wei Liu; Xiao H Liu; Wei Tang; Hong B Gao; Bing N Zhou; Liang P Zhou
Journal:  J Magn Reson Imaging       Date:  2018-02-07       Impact factor: 4.813

7.  Conspicuity of peripheral zone prostate cancer on computed diffusion-weighted imaging: comparison of cDWI1500, cDWI2000, and cDWI3000.

Authors:  Metin Vural; Gökhan Ertaş; Aslıhan Onay; Ömer Acar; Tarık Esen; Yeşim Sağlıcan; Hale Pınar Zengingönül; Sergin Akpek
Journal:  Biomed Res Int       Date:  2014-12-01       Impact factor: 3.411

8.  Predicting Prostate Biopsy Outcomes: A Preliminary Investigation on Screening with Ultrahigh B-Value Diffusion-Weighted Imaging as an Innovative Diagnostic Biomarker.

Authors:  Kun Zhang; Yanguang Shen; Xu Zhang; Lu Ma; Haiyi Wang; Ningyu An; Aitao Guo; Huiyi Ye
Journal:  PLoS One       Date:  2016-03-10       Impact factor: 3.240

9.  MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.

Authors:  Veeru Kasivisvanathan; Antti S Rannikko; Marcelo Borghi; Valeria Panebianco; Lance A Mynderse; Markku H Vaarala; Alberto Briganti; Lars Budäus; Giles Hellawell; Richard G Hindley; Monique J Roobol; Scott Eggener; Maneesh Ghei; Arnauld Villers; Franck Bladou; Geert M Villeirs; Jaspal Virdi; Silvan Boxler; Grégoire Robert; Paras B Singh; Wulphert Venderink; Boris A Hadaschik; Alain Ruffion; Jim C Hu; Daniel Margolis; Sébastien Crouzet; Laurence Klotz; Samir S Taneja; Peter Pinto; Inderbir Gill; Clare Allen; Francesco Giganti; Alex Freeman; Stephen Morris; Shonit Punwani; Norman R Williams; Chris Brew-Graves; Jonathan Deeks; Yemisi Takwoingi; Mark Emberton; Caroline M Moore
Journal:  N Engl J Med       Date:  2018-03-18       Impact factor: 176.079

10.  High b value (2,000 s/mm2) diffusion-weighted magnetic resonance imaging in prostate cancer at 3 Tesla: comparison with 1,000 s/mm2 for tumor conspicuity and discrimination of aggressiveness.

Authors:  Tsutomu Tamada; Naoki Kanomata; Teruki Sone; Yoshimasa Jo; Yoshiyuki Miyaji; Hiroki Higashi; Akira Yamamoto; Katsuyoshi Ito
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

View more
  1 in total

1.  Innovations in prostate cancer: introductory editorial.

Authors:  Jurgen J Fütterer; Chan Kyo Kim; Daniel J Margolis
Journal:  Br J Radiol       Date:  2022-03       Impact factor: 3.039

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.